GRUSF · Grown Rogue International Inc.
Market Cap
$107.47M
Shares
249.94M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.43
Open$0.43
Day$0.43–0.44
52W close$0.27–0.52
Avg vol 30d109K
Short int11K · 0.0% float · 1.0d
Short vol38%
Last earningsAug 4, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 5
Up next
Next earnings call
Oct 6, 2026
Est · unconfirmed
· in 3 wks
filed Aug 5, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-8.5%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
AI Brief
Q2 FY26 earnings call · Aug 4, 2026
Q2 FY26
TL;DR. Grown Rogue reported Q2 revenue of $11.3 million (up 41% YoY) and raised 2026 revenue guidance to $38–$41 million and 2027 revenue guidance to $55–$63 million, while posting a GAAP net loss of $1.5 million driven by ~$0.8 million of non-cash derivative/warrant fair-value losses.
Bullish
- + Oregon indoor bulk ASP recovered to $592/lb from $480 in Q1, with cost per pound at $326.
Bearish
- − 2026 guidance assumes ~$1.5–$2.0M of pre-revenue startup losses in each of Illinois and Minnesota.
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.4 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+9%
above
Price vs 50-day avg
−3%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
64%
mid-range
Momentum
relative strength
1-month return
−7%
trailing
6-month return
+48%
trailing
YTD return
−17%
this year
Relative strength
+30%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Accumulating
+100% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -90.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
2 holders — near 2-yr high, broad support
Squeeze score
19
low risk · 0–100
Fundamentals
Revenue growth
+22%
Y/Y
Gross margin
44%
contracting
EPS growth
+113%
Y/Y
Free cash flow
$-1.1M
Balance sheet
$2.5M
net debt
Quant / Vol
risk profile
Volatility
86%
annualized · 1-yr
Max drawdown
−48%
past year
ATR
5.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 4, 2026
Long-term (3-5 year)
Revenue growth
25%
Profit growth (Adjusted EBITDA)
Non-GAAP
35%
Return on Incremental Invested Capital (ROIIC)
Non-GAAP
at least 75%
Long-term (3-5 year), using 2027 as the base year
Revenue growth
25%
Adjusted EBITDA growth
Non-GAAP
35%
Return on Incremental Invested Capital (ROIIC)
Non-GAAP
at least 75%
2026
Revenue
$38M – $41M
prior FY $32.43M
midpoint +21.8% Y/Y
Adjusted EBITDA
Non-GAAP
$7M – $9M
2027
Revenue
$55M – $63M
prior FY $32.43M
midpoint +81.9% Y/Y
Adjusted EBITDA
Non-GAAP
$14M – $18M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+9%
Bullish
Price vs 50-day avg
−3%
Neutral
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
64%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Accumulating
+100% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -90.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
2 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $0
Now $0 · 64%
Range high $1
vs 200-day avg +9%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GRUSF
this stock
Grown Rogue International Inc.
|
$107.47M | -17.3% | +21.8% | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$59.80B | +22.2% | — | — | 0.1% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$45.49B | +25.6% | +4.3% | 64.0 | 3.2% |
|
GALDY
Galderma Group AG/ADR
|
$44.48B | -8.0% | — | — | 0.0% |
|
HLN
Haleon plc
|
$41.16B | -7.4% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
2
- % held
- 0.1%
- Net QoQ
- +200.0K sh
- Top holder
- Beaumont Financial Adviso…
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GRUSF | -1.4% | -6.5% | +48.3% | -5.5% | -17.3% |
| SPY | +0.6% | -0.8% | +18.2% | -0.6% | +11.8% |
| vs SPY | -2.0% | -5.7% | +30.1% | -5.0% | -29.1% |